We are developing a potential break-through COVID-19 immunisation. Learn More
Press and Media Information

Media

Press Releases.

Join our Media Database

Receive our Open Care press releases and company updates directly to your inbox.
Thank you for subscribing to our media database
Oops! Something went wrong while submitting the form.

Media Information.

Press Kit

Our press kit includes access to company brand assets and team profiles which are available for download.
Access Press Kit

Media Enquiries

+1 929 312 3639 (US)
+44 20 3318 8326 (UK)
+61 3 9917 3437 (AU)

For all press and media enquiries, please call our media relations team, email us at press@open.care or send us an enquiry using our form.
Send Media Enquiry

AI Smart Web App.

We are developing a smart AI web app as part of Immuno® that will enable individuals to build stronger immune systems and take control of their health.

  • A vast collection of components
  • A vast collection of components
  • A vast collection of components
Feature Snapshot

Make an impact with Foray.

A flexible aesthetic makes Foray the perfect starting point for all websites, from portfolio to product brochure.
  • A massive interface kit
  • Your home base
  • Fully responsive design
Foray’s flexible aesthetic makes it the perfect starting point for websites of all types.
Plan a consultation

Media Request

Your Details
Enquiry
Organisation Information
Your request has been received. One of our team will be in contact shortly.
Oops! Something went wrong while submitting the form.
Disclaimer

The Immubio platform and ImmubioCV are currently in the early-stage development phase. The Immubio platform and any produced immunisations are being developed for government direct sales and as such we will not sell directly to consumers. Our Immubio range of immunisations are yet to be tested for safety and effectiveness. Studies are planned to confirm safety and effectiveness. Any claims made on this site or in Open Care documents have not been reviewed or evaluated by any international or local health regulators including but not limited to the FDA, HC, EMA or TGA. Until the Immubio platform and ImmubioCV products are registered with the relevant health regulators, all Immubio products that we develop will not be available for use or supply except for use in clinical trials. If you have a serious health concern, please follow official government and medical guidelines and seek professional medical advice.

Build with Foray

Here are the features you’ll want.

A flexible aesthetic makes Foray the perfect starting point for all websites, from portfolio to product brochure.
Plan a consultation
  • Bring your site to life with a suite of dynamic pages powered by Webflow CMS.
  • A beautiful, flexible aesthetic that makes beautiful websites accessible to everyone.
  • Foray displays beautifully on screens of all sizes so your customers will be engaged wherever they are.
  • Build rapidly with Foray’s broad collection of responsive interface elements.